CHAPTER 9: Generic Control in Other Jurisdictions Check Access

In the past ten years there has been an increasing trend for countries to adopt some form of structure-specific generic legislation. This has been driven by the appearance of so many new psychoactive substances and the limitations this places on controlling each by name. Until 2010 there were only two countries in Europe that used generic control, but by 2017 this had increased to 16. Several countries outside Europe now also use this procedure as well as others that have enacted analogue control. New Zealand implemented generic controls in their Misuse of Drugs Act 1975. These are shown in detail and cover derivatives of amphetamine, methaqualone and dimethyltryptamine and differ from those used in the United Kingdom Misuse of Drugs Act 1971. Examples are also provided of the generic controls in Israel, Switzerland, Germany, New South Wales and China. All use unique structural determinants that in some cases have a remarkably broad scope.